Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 147 Results

Intervention Indication Therapeutic Area Year Actions
Buprenorphine for Opioid Dependence Buprenorphine (CAM2038; BuTrans; Subutex; RBP-6000; Probuphine) Opioid dependence Mental and Behavioural Health 2021 View  |  Download
Burosumab for tumour-induced osteomalacia Burosumab (Crystiva; KRN23) Osteomalacia Musculoskeletal System 2021 View  |  Download
Cabozantinib for treating differentiated thyroid cancer Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) Differentiated thyroid cancer (DTC) Head and Neck Cancer 2021 View  |  Download
Cabozantinib in combination with atezolizumab for advanced hepatocellular carcinoma –first line Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2021 View  |  Download
Canakinumab for Schnitzler syndrome Canakinumab (Ilaris; ACZ885) Schnitzler syndrome Immunology 2021 View  |  Download
Canakinumab in addition to pembrolizumab and platinum-based chemotherapy for locally advanced or metastatic non-small-cell lung cancer (NSCLC) Canakinumab (Ilaris; ACZ885) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Capmatinib for advanced non-small cell lung cancer Capmatinib (INC280) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Cediranib with olaparib for previously treated platinum resistant recurrent ovarian cancer Cediranib (Recentin; AZD2171) , Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Ovarian cancer Female Reproductive Cancer 2021 View  |  Download
Cemiplimab in combination with chemotherapy for advanced or metastatic non-small cell lung cancer – first-line Cemiplimab (Libtayo; REGN2810) , Ipilimumab (Yervoy; BMS 734016; MDX 101) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Ciltacabtagene autoleucel for relapsed and refractory multiple myeloma Ciltacabtagene Autoleucel (JNJ-68284528; LCAR-B38M CAR-T cell therapy; LCAR-B38M; JNJ 4528) Multiple myeloma (MM) Haematological Cancer and Lymphomas , Haematology 2021 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications